Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy bodies
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, M. van de Beek,…
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, M. van de Beek,…
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, L.N.C. Visser, H.M.A. Hendriksen,…
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
The Journal of Prevention of Alzheimer's Disease S. Ylä-Herttuala, M. Hakulinen, P. Poutiainen, J. Lötjönen,…
The theme of RSNA 2021 was “Redefining Radiology,” and, according to our CEO Richard Hausmann, the event delivered. Read Richard's 5 takeaways, from the potential of AI for radiology to the importance of data for patient care.
Combinostics will demonstrate the features of cNeuro® 2.0, the latest release to their AI-based suite of products, and applications under development at RSNA 2021.
Arterys has partnered with Combinostics to offer the most comprehensive neuro AI suite on the market, covering a broad set of applications in neuroradiology .
Greg Kingston joins the Combinostics leadership team as Chief Marketing Officer (CMO). He has more than a decade of experience in the medical imaging software domain and a focus in AI-based technology.